Citation: Yan Pan, Fuyong Jiao. Challenges in early diagnosis and treatment of Kawasaki disease[J]. AIMS Allergy and Immunology, 2024, 8(4): 213-215. doi: 10.3934/Allergy.2024012
[1] | Center for Diagnosis and Treatment of Kawasaki Disease/Children's Hospital of Shaanxi Provincial People's Hospital.Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China. Zhongguo DangDai ErKe ZaZhi (2023) 25: 1198-1210. https://doi:10.7499/j.issn.1008-8830.2309038 |
[2] | Rife E, Gedalia A (2020) Kawasaki disease: An Update. Curr Rheumatol Rep 22: 75. https://doi:10.1007/s11926-020-00941-4 |
[3] | Broderick C, Kobayashi S, Suto M, et al. (2023) Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database Syst Rev 1: CD014884. https://doi:10.1002/14651858.CD014884.pub2 |
[4] | Agarwal S, Agrawal DK (2017) Kawasaki disease: Etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol 13: 247-258. https://doi:10.1080/1744666X.2017.1232165 |
[5] | Jiao F, Pan Y, Du Z, et al. (2024) Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China. BMC Pediatr 24: 477. https://doi:10.1186/s12887-024-04961-2 |